Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $617,098 - $727,477
1,175 New
1,175 $684,000
Q2 2023

Aug 01, 2023

BUY
$350.74 - $468.98 $54,013 - $72,222
154 New
154 $72,000
Q4 2022

Jan 23, 2023

SELL
$321.55 - $374.67 $22,508 - $26,226
-70 Reduced 53.85%
60 $22,000
Q1 2022

May 04, 2022

SELL
$234.69 - $291.66 $14,081 - $17,499
-60 Reduced 31.58%
130 $37,000
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $42,721 - $53,017
-190 Reduced 50.0%
190 $52,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $84,208 - $103,629
380 New
380 $88,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.